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Abstract
Introduction A patient with a total hip replacement
developed optic, acoustic and peripheral neuropathy from
metal ions intoxication, due to the wear products released
from the prosthesis. Subsequently the kinetics of the metal
ions was studied.
Materials and methods Massive wear and acute intoxi-
cation allowed a study of the metal ions kinetics and of
EDTA treatment.
Results Plasma and other organic fluids were saturated by
each of the metal ions released from the exposed surface
according to the solubility of each ion; a larger fraction of
Co ions was bound within red cells, while the plasmatic
fraction appeared more movable. In a patient with a pros-
thesis subjected to wear, the ions released are from the
prosthetic and from the debris surface (spread in the body).
The latter is a function of the number and size of particles.
Discussion Revision of the prosthesis from the point of
view of the metal ions kinetics corresponded to a reduction
of the releasing surface because of debris washed out by
irrigation and tissue excision; however, the metal particles
spread by lymphatic circulation continued to release ions
even though the source of wear had been removed. Early
diagnosis of high metal wear can be ascertained with mass
spectrometry and after revision high levels of metal ions
can only be reduced with repeated chelating treatment. It is
preferable not to revise fractured ceramic components with
a polyethylene–metal articulation.
Keywords Total hip replacement  Cobalt intoxication 
Metal ions  Foreign body reaction  Prosthetic wear
Introduction
The increasing diffusion of metal-on-metal bearings in
total hip replacement has renewed in recent years not only
the interest for the local effects of metal particles, but also
for the potential damages of ions released by the surface of
the prosthesis or by the products of wear [1–4]. In general,
the documented levels of metal ions in blood, plasma or
urine of different types of implant [5–13] or correlated
conditions like loosening [14, 15] are not comparable with
those observed in professionally exposed workers, due to
the way of absorption (usually inhalation) and also the
excretion rate is very different [16–18]. However, in both
situations the risks connected with intoxication have been
considered so far as potential. Intoxication by wear prod-
ucts of a hip prosthesis has been to the best of our
knowledge rarely observed [19–21].
The kinetics of metal ions in THR population, even if
already studied [3, 5, 7, 9–15, 19–24], remain a compli-
cated topic because of the difficulty in determining the
release rate and the active surface which includes both the
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metallic components of the prosthesis and the wear parti-
cles that are disseminated widely in the body through the
lymphatics [22–24].
A severe metal ion intoxication [20] allowed a detailed
study of the parameters of wear and the kinetics of metal
ions released in the human body by a THR. It nevertheless
was an interesting case to apply and analyse the effects of
the therapy with chelating agent (EDTA), which is already
been studied and currently used only in occupational metal
intoxications [16–18, 25] but never before in a THR.
Materials and methods
Clinical background
A 58-year-old female patient had a THR with a titanium
cementless stem and a ceramic–ceramic coupling, when
she felt sudden pain in her hip and the head was found to be
broken. A polyethylene liner coupled with Co–Cr head
were inserted in the place of the ceramic components,
while the stem and the cup were left in place. Five months
later the patient started to complain of reduction of sight
and hearing whose aetiology remained unknown. Two
months later her conditions worsened resulting in an almost
complete loss of sight, hearing, combined with weakness of
the upper and lower limbs, paresthesia, diffused anaesthe-
sia constraining the patient to a wheelchair. The aetiology
of neuropathy was revealed 1 year later when metal ions
levels were measured in biological fluids [19].
The complete clinical records including X-rays and CT
imaging, the components of the removed hip prosthesis, the
tissue histology and the periprosthetic fluid samples col-
lected at revision were available for the study.
Wear particles analysis
The analysis of the wear particles was carried out on the
samples of interstitial fluid drained during revision. They
were diluted in distilled water (1:2), centrifuged at 2,500 rpm
for 5 min and the deposit was suspended again in a solution of
hydrochloric acid (8%) then centrifuged at 2,500 rpm for
5 min. The procedure was repeated twice with distilled water
to remove the acid. The final deposit was put on glass and
polystyrene slides which were processed for SEM and EDX
analysis. The slides were fixed on stubs with conducting tape,
coated with a thin layer of gold in a vacuum sputter Emitech
K550 (Emitech United, Ashford, Kent, UK) and studied with
a FEG XL30 scanning electron microscope (Philips, Eind-
hoven, Netherlands) in the direct and backscattered mode. A
quantitative EDX analysis was performed with an EDAX
(Edax Inc., Mahwah, New Jersey, USA) device equipped
with Genesis 2000 software.
Metal ions determination
Blood samples were obtained using a disposable intrave-
nous cannula; the first 10 ml were discarded and further
10 ml of blood were withdrawn and transferred into sep-
arate 2 ml tubes containing lithium-heparin anticoagulant.
The blood then was centrifuged at 3,000 rpm for 10 min
and the plasma was frozen and stored at -80C until the
analysis was performed.
To collect a sample of urine the patient was catheterized
and a sample for analysis was drawn from the sac con-
sidering the total volume. Cephal-rachidean fluid was
obtained by rachiocentesis at lower lumbar level.
ICP-MS (ELAN DRC II, Perkin Elmer, Waltham, USA)
equipped with dynamic cell reaction (DRC) was used for
determinations.
The samples of plasma and blood were diluted with
Triton 0.05%. Urine and cephal-rachidean fluid samples
were bi-distilled with water, for inorganic trace analysis
(Merck KgaA) [26]. Traces of titanium in the urine sample
was determined by a direct atomic absorption method, a
spectroscopy AAS graphite tube atomizer furnace (Varian
Duo, GTA 120, AA 240 Z).
The calibration standards were prepared by standard
solutions of single elements ranging from 0.5 to 1,000 lg/l:
cobalt in HNO3 2% mono elemental standard solution
(Carlo Erba Reagenti, Milano, Italy); vanadium in HNO3
5% mono elemental standard solution (Carlo Erba Rea-
genti, Milano, Italy); chromium in HCl atomic absorption
standard solution (Sigma-Aldrich, Milwaukee, USA);
molybdenum and titanium in H2O atomic absorption
standard solution (Sigma-Aldrich, Milwaukee, USA).
The limit of detection (LOD), calculated as three stan-
dard deviations of the background signal obtained on ten
blind samples were Cr: 0.05 lg/l (U, P, B); Co: 0.05 lg/l
(U, P), 0.1 lg/l (B); Mo: 0.05 lg/l (U), 0.1 lg/l (P, B); V:
0.05 lg/l (U, P, B).
Results
Massive third body wear of a THR Co–Cr–Mo head
(Fig. 1a) was produced after removal of a broken cera-
mic head by the particles of the same material which
remained embedded on the surface of the polyethylene
socket used in revision (Fig. 1c). There were no local
troubles in the hip, however, from the X-rays and the CT
performed, radiopaque longitudinal deposits along the
diaphysis of the femur and in the posterior iliac fossa
were observed and initially interpreted as ossifications
(Fig. 2a–b).
The clinical disease with optic, acoustic and peripheral
neuropathy had been previously reported [20] and the
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temporal sequence of the wear history and metal ions
release is presented in Fig. 3.
The prosthetic head had lost about 1/3 of its volume
(Fig. 1a); the neck and the stem were also damaged, with
loss of material and superficial fretting (Fig. 1b). The
weight loss of the components (calculated by the difference
between the manufacturer specifications and the worn
components) was 15 g for the Co–Cr–Mo head and 0.72 g
for the titanium stem.
Two wear modes were documented by the surface
analysis of the removed prosthetic components: third body
wear of the Co–Cr–Mo head (Fig. 1a) and fretting of the
neck and of the stem porous coating (Fig. 1b).
Metal particles had spread along the intermuscular
septa, forming a bursa whose surface was heavily stained
by the black deposits. There was no fibrous capsule
around the prosthetic joint and this space was in conti-
nuity with the bursae extending both distally and
proximally.
Particles phagocytosis by macrophages in the peripros-
thetic tissue was scanty (Fig. 4); in contrast, metal particles
were collected in a suspension of the interstitial fluid which
diffused far from the joint between the muscles in absence
of a fibrous capsule around the prosthetic joint (Fig. 2a).
SEM observation coupled with EDX analysis allowed to
distinguish in the smears of the interstitial fluid the Co–Cr–
Mo particles from those of titanium (Fig. 5a–c). The latter
were few, heterogeneously distributed and could only be
identified in few fields. Ceramic particles were occasion-
ally observed in histological sections (Fig. 4), but not in the
interstitial fluid smears.
Fig. 1 a Massive polar wear of the Co–Cr–Mo head was observed;
surface damage and loss of material from the neck and Morse cone
was also present (2nd revision). b The Morse cone was deformed and
scraped (fretting) with loss of metal from the tip; signs of fretting and
loss of the porous coating on the lateral surface were evident (2nd
revision). c Ceramic particles set in the polyethylene liner causing
third body wear with the Co–Cr–Mo alloy head (2nd revision); 259
Fig. 2 a, b X-rays taken 14 months after the first revision when a
Co–Cr–Mo alloy head and a polyethylene liner were inserted on the
original titanium stem and cup in substitution of the broken ceramic
head and ceramic liner. The radiopaque deposits extending distally
between the vastus lateralis and the fascia lata were at first interpreted
as ossifications, but resulted to be accumulation of metallic debris
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From the time of the diagnosis to the removal of the
prosthesis (70 days) therapy with a chelating agent
(EDTA) was performed at regular intervals of about
7 days. Both Co and Cr in plasma after an initial decrement
following the two first EDTA administrations increased
again, even if at levels lower than before. Mo levels were
relatively low in respect to Co and Cr, without any corre-
lation with the proportion of the three elements in the alloy
(ISO 5832/12: Co 59.5–65.5%, Cr 26–30%; Mo 5–7%).
From the third EDTA administration onward there was a
short fall of the soluble ions level in plasma which lasted
for about 3 days and gave a swinging profile to the graph
(Table 1). During the 2 months of therapy the decrement of
Co levels were more evident in blood than in plasma; in the
latter, the mean level of Co ions was about a half of that in
blood. Urine levels showed a peak after each EDTA
administration (Table 2).
Cr levels in plasma and blood after the initial decrement
maintained a constant concentration throughout the whole
period, with higher values in plasma than in blood. The Cr
urinary excretion pattern did not differ from that of Co, but
the absolute values of metal ions eliminated were higher in
the latter (Table 3). The Mo ion levels were in the range of
2–4 lg/l with no significant differences between plasma
and blood. The removal of the prosthesis produced a dec-
rement of about half of Co in plasma and blood, while in Cr
reduction was less evident (Tables 2, 3).
Cephal-rachidean fluid was assessed twice at days 8, and
108 with the following concentrations: Co 11.4–2.6 lg/l;
Cr 4.4–0.8 lg/l; Mo 18–0.5 lg/l.
Due to interference and sensibility Ti ion levels were
assessed only in urine before and ten times after the
removal of the prosthesis. The concentrations of these ions
were 21 lg/l before the operation and decreased to
9–10 lg/l in the repeated dosages after the surgery. The
pre-operative values were comparable with the reference
values in patients with titanium alloy prosthesis with a
regular wear rate [8] and the post-operative values were
similar to normal population [25].
Discussion
A combination of factors such as the inappropriate revision
of the broken ceramic head, which caused the third body
wear and the massive and fast production of Co–Cr–Mo
particles, but also, the delayed diagnosis of the neuropathy
aetiology and the medical treatment with a chelating agent
offered the chance to study the kinetics of metal ions
released by a joint prosthesis with a high wear rate. Che-
lating therapy is currently used in occupational metal
intoxications, but never before in a THR.
It has been well documented that loosened hip pros-
theses have higher serum levels of metals than successful
Fig. 3 Timetable of Ti and
Co–Cr–Mo alloy particles
production and end-points of the
implant history. The titanium
hip prosthesis with a ceramic–
ceramic coupling has been
implanted 5 years before time
t0. The patient could walk
without local complaints until
time t2, when neuropathy
developed
Fig. 4 Haematoxylin–eosin (2nd revision, 2009). Metallic debris
particles in the periprosthetic tissue: few of them have been
phagocytosed by macrophages (yellow arrow) while most of them
are free or form clusters within the fibrin clot. Ceramic particles left
by the 1st revision are also evident (green arrows)
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and stable prostheses [14, 15] as well as metal-on-metal
prostheses have higher serum values of metals than metal-
on-polyethylene couplings [6, 11] and also the head
diameter of metal-on-metal prostheses showed a direct
correlation with the level of soluble metals [13].
Since the release occurs from the surface of the
implanted material [27], the surface available for release
from a prosthesis is limited to about 20 cm2, but it
increases remarkably when wear particles are produced.
Metal particles can be easily identified in stained tissue
sections or on smears of the periprosthetic fluid as irregu-
lar, black bodies [28, 29]; however, morphological size
assessment with light microscopy is questionable as it is
not possible to distinguish individual particles from clus-
ters. SEM examination of the particles suspension as car-
ried out in this study was the only reliable method of
measurement.
The surface increments of the alloy volume lost by the
prosthetic components with respect to the bulk materials
can explain the very high release of soluble ions in blood,
plasma and urine. A further factor was the high rate of
particles production, which favoured diffusion of the par-
ticles-loaded interstitial fluid, rather than the collection
around the prosthetic joint of a granulation tissue formed
by macrophage. This aspect was well documented in
X-rays by the presence of radiopaque deposits mimicking
an ossifying myositis [30]. Also in the case reported by
Steens et al. [21] with similar symptoms of neuropathy and
in that of Oldenburg et al. [19], an unusually high quantity
of metallic debris was evident around the articulating space
of the prosthesis, which indicated a high wear rate of these
metal-on-metal bearings but with the products of wear
contained by a capsule around the prosthetic joint. A
massive metallosis by third body wear of ceramic particles
embedded in the bearing surface of a polyethylene cup was
also reported by Kempf and Semlitsch [31], but the metal
ions released by the stainless steel debris did not provide
evidence of intoxication. Other examples of third body
wear have been reported with fragments of porous metal
surface [32].
The toxicokinetics of metal ions from joint replacements
is completely different from that of the inhalation exposure
of these metal ions, as well as of the other exposures such
dermatological or oral route, which are common to pro-
fessionally exposed workers or to the general population
[25, 33], because in the former the ions source is inside the
body.
The treatment with EDTA in this case caused a short-
term lowering of the levels of Co, Cr and Mo in plasma and
a corresponding peak of the urinary excretion; however,
after approximately 3 days they increased again. This trend
Fig. 5 a SEM low power view (2,5009). Metal debris present in the
interstitial fluids drained during the second revision: since the
particles were embedded in a fibrin clot repeated lavages in a weak
acid solution were necessary before smearing the fluid on a
polystyrene slide. b SEM (20,0009). Particles partially embedded
in organic material not completely digested by hydrochloric acid
solution. c Energy dispersive X-rays analysis of the same field of 5b
documented they are Co–Cr–Mo alloy particles (green for Co
emission)
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can be explained by the particular situation of a patient
with prosthesis subjected to wear. Plasma and other organic
fluids are saturated by each of the metal ions released from
the active surface according to the solubility curve of each
ion [34]; the chelating agent binds and removes part of the
soluble ions present in plasma, but further release from the
active surface occurs until a new balance is established.
The revision of the prosthesis stopped the wear process and
also reduced the releasing surface of the disseminated
metal debris (washed out by irrigation and by tissue
resection during surgery). This produced a significant
lowering of cobalt in blood and plasma, however, the effect
was less evident on levels of chromium and molybdenum.
When tissue deposits of Cr ions are very high, as occurred
in this case, the metal release is slow and it can take several
years to de-saturate the tissues. The chelating therapy,
moreover, has been proved to be less effective on chro-
mium than on cobalt [25]. After revision there was a
rebound effect on the levels of cobalt and chromium, as
after an EDTA administration, but without a peak of uri-
nary excretion due to the fact that the soluble ions were
removed by open irrigation through the surgical wound.
Table 1 Blood levels of cobalt, chromium and molybdenum ions from the diagnosis to the end of therapy with EDTA
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Therefore, the response to revision and to the repeated
chelating treatments showed a typical saturation pattern
governed by the solubility curves of the ions involved.
Comparing the levels and trends of Co ions in plasma
and whole blood during the pre-operative time interval, it
was observed that the blood concentration was about
double than in plasma and that decrements induced by the
chelating treatment were more evident in the latter. This
may indicate that a larger fraction of the cobalt released by
the implant and the wear particles is bound within the red
cells and that the chelating agent removes the more
movable plasmatic fraction. After each chelating treatment
there was a re-balance, with a passage of ions from the red
cell fraction to the serum. In the post-operative period,
when the levels of cobalt in blood were reduced to about
1/5th, the effect was less evident.
The ratio of the individual constituent elements mea-
sured in plasma and whole blood in this case did not reflect
the Co–Cr–Mo alloy composition (ISO 5832/12). This was
not unexpected because corrosion products in aqueous
electrolytes can be hydroxides, oxides, soluble salts or
occasionally complexes. Therefore, no correlation is
Table 2 Plasma, blood and urine levels of cobalt ions from the diagnosis to the end of therapy with EDTA
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possible between the metal composition of the alloy and
the ions levels [34].
Peripheral neuropathies were reported after occupational
inhalation exposure to cobalt [35, 36]; the documented
levels of ions in blood were 234 lg/l and the time of
exposure corresponded to 20 months, working 50 h a
week. After oral treatment with cobalt chloride maintained
for over 2.5 years optic atrophy was observed [37], another
case developed with the same treatment for 6 months limbs
paraesthesia, unsteady gait, impaired hearing and dusty
spells [38]. Our data suggest that high Co ions levels,
induced by pathological prosthetic wear, can be a cause of
neuropathy and this observation has also been confirmed by
two other recent reports [39, 40].
Titanium wear particles also originated from the stem
and the neck of the prosthesis; however, they were few
compared to the mass of Co–Cr–Mo alloy particles.
The concentration of titanium ions was comparable with
the reference values [25] and with those of patients with
titanium alloy prosthesis with a regular wear rate [8, 37].
Table 3 Plasma, blood and urine levels of chromium ions from the diagnosis to the end of therapy with EDTA
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After the prosthesis removal, the titanium levels in urine
showed a progressive decrement which stabilized at about
10 lg/l. Both the analysis of debris and the level of tita-
nium ions did not suggest a role of the latter in the acute
intoxication. The ion kinetics documented in this study can
be explained by the spreading of the metallic debris by
lymphatic or haematogenous route to lymph nodes, spleen,
liver and reticulo-endothelial system in general: from these
sites the accumulated debris continue to release ions even
after the source of wear has been removed.
From the clinical point of view, three suggestions come
out:
1. It is preferable not to revise fractured ceramic com-
ponents with a polyethylene–metal articulation.
2. An early diagnosis of any condition causing excessive
wear is a requisite to prevent not only local compli-
cations like periprosthetic bone loss, but also a
possible systemic intoxication by metal ions [21, 36,
37, 39, 40]. In this respect, inductively coupled mass
spectrometry determinations of soluble metal ions in
biological fluids should be considered as an unavoid-
able test when suspecting an increased wear rate of the
joint prostheses metal components.
3. When massive diffusion of particles through the
reticulo-endothelial system has taken place, chelating
agents can be considered as an adjuvant therapy to be
associated with the implant revision.
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